 "Sun Pharma second quarter net profit rises 13% to Rs 2,047 crore")
Drug major Sun Pharmaceutical Industries on Tuesday reported a 12.92 per cent rise in its consolidated net profit to Rs 2,047.01 crore for the quarter ended on September 30, 2021.
The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
Consolidated revenue from operations stood at Rs 9,625.93 crore for the quarter under consideration against Rs Rs 8,553.13 crore for the same period a year ago, it added.
Shares of Sun Pharmaceutical Industries were trading at Rs 816.05 per scrip on BSE, up 0.53 per cent from its previous close.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app